Results 161 to 170 of about 4,996,457 (177)

DNA-Conjugated Gold Nanoparticles as High-Mass Probes in Imaging Mass Cytometry

ACS Applied Bio Materials, 2019
We employ imaging mass cytometry (IMC) to investigate in vitro uptake and cellular distribution of DNA-functionalized gold nanoparticles (AuNPs). IMC enables the multiparametric imaging of cell components and allows for the detection of AuNPs in cells ...
Derek Wilson, Chun Peng, Jennifer I L Chen   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Abstract 1144: Development of imaging mass cytometry (IMC) as a tool to characterize circulating tumor cells (CTCs) in pre-clinical mouse models

Cancer Research
Abstract Metastasis is in part due to circulating tumor cells (CTCs), especially CTC clusters, which are associated with poor prognosis and treatment resistance. CTCs increase in numbers after biopsy, surgery, and during neo-adjuvant treatment.
Milind Pore, Balamurugan Kuppusamy, Devynn Breen, Paul Mallory, Abigail Atkinson, Ashley Cardamone, Christine Newkirk, Lois McKennett, Shikha Sharan, William Bocik, Esta Sterneck   +10 more
openaire   +1 more source

Ruthenium counterstaining for imaging mass cytometry

Journal of Pathology, 2018
Imaging mass cytometry is a novel imaging modality that enables simultaneous antibody-based detection of >40 epitopes and molecules in tissue sections at subcellular resolution by the use of isotopically pure metal tags.
Bernd Bodenmiller, Luis M Montuenga, Raúl Catena   +2 more
exaly   +2 more sources

Abstract 7124: Imaging mass cytometry (IMC) reveals distinct intratumoral B and T regulatory cell populations in responder versus non-responder soft tissue sarcoma (STS) patients before treatment with immune checkpoint blockade (ICB)

Cancer Research
Abstract Background: STS are poorly understood cancers for which systemic therapy options are limited. Recent evidence suggests that some patients with two types of STS (undifferentiated pleomorphic sarcoma, UPS; dedifferentiated liposarcoma, DDLPS) benefit from ICB.
Laurence P. Diggs, Elise Nassif Haddad, Susmita Kumari, Varshini Arunkumar, Sammy Ferri-Borgogno, Samuel Mok, Duncan Mak, Angelique Lin, Madeline McAllister, Akshay Basi, Manoj Chelvanambi, Javier Gomez, Jared Burks, Davis Ingram, Khalida Wani, Natalie Duarte, Trevor McKee, Alexander Lazar, Jennifer Wargo, Christina Roland, Emily Keung   +20 more
openaire   +1 more source

(1265) Exploration of Intragraft T Cell Phenotypes in Minimal Acute Cellular Rejection (ACR) Using Imaging Mass Cytometry (IMC)

The Journal of Heart and Lung Transplantation, 2023
S. Beber, S. Moshkelgosha, M. Cheung, D. Hedley, L. Levy, J. Samuels, B. Renaud-Picard, D. Hwang, T. Martinu, S. Juvet   +9 more
openaire   +1 more source

Mass Cytometry, Imaging Mass Cytometry, and Multiplexed Ion Beam Imaging Use in a Clinical Setting

Clinics in Laboratory Medicine, 2021
Raymond Devine
exaly  

Research Techniques Made Simple: Experimental Methodology for Imaging Mass Cytometry

Journal of Investigative Dermatology, 2021
Vincent Piguet, Lihi Eder, Saeed Khalili   +2 more
exaly  

Molecular architecture of proliferative lupus nephritis as elucidated using 50-plex imaging mass cytometry proteomics

Clinical Immunology, 2023
Junjun Zheng
exaly  

WED-379 Intrahepatic changes in immunologic and virologic markers during siRNA JNJ-73763989 (JNJ-3989) based treatment of chronic hepatitis B (CHB) patients: imaging mass cytometry (IMC) analyses from the INSIGHT study

Journal of Hepatology
Kim Thys, Marjolein Crabbe, Hans Wils, Hinrich Goehlmann, Simon Verheijden, Pietro Lampertico, Tarik Asselah, Edward J. Gane, Scott K. Fung, Patrick Kennedy, Thomas Vanwolleghem, Ewa Janczewska, Julian Schulze zur Wiesch, Mark S. Sulkowski, Carine Guinard-Azadian, Michael Biermer, Oliver Lenz   +16 more
openaire   +1 more source

An imaging mass cytometry immunophenotyping panel for non-human primate tissues

Frontiers in Immunology, 2022
Simone A Joosten, T H M Ottenhoff, Ottenhoff Tom H M   +2 more
exaly